NEUROTOXICITY: The most sensationalistic and controversial issue regarding MDMA is claims of neurotoxicity in humans. At high doses in animals (mice, rats, monkeys, and baboons) a profound loss of serotonin axons (and dopamine axons in some species/dosing regimens) is produced.[48] The cell body itself is not destroyed. How or why MDMA was able to produce this distinctive pattern of damage has been the subject of a considerable amount of speculation, with a number of reasonable theories proposed, none of which quite fit all the experimental evidence. Recent research has compellingly tied together much of the disparate evidence by demonstrating that the key factor in MDMA neurotoxicity was hyperthermia.[49] Animals given MDMA do not normally suffer neurotoxicity if hyperthermia is avoided, which can be accomplished by any number of means, from sedation, restraint, or even simply placing them in a cool room. The exact mechanism of toxicity is still not known, but the most likely route is the metabolic breakdown of MDMA or a metabolite of MDMA within the axon producing reactive oxygen species (such as superoxide), that, if not neutralized by endogenous defenses (superoxide dismutase, etc.), will readily react with the local antioxidant supply, then, as antioxidant levels drop, damage the axon itself. It seems likely that the role of hyperthermia in MDMA neurotoxicity involves the reduced activity of one or more of these protective enzymes, but more research is needed. (In my opinion, the current best explanation of the source of reactive oxygen species is the N-demethylation/deamination of MDMA/MDA by monoamine oxidase.) As a practical matter, the role of hyperthermia in both neurotoxicity and death/injury makes the 'rave' settings in which MDMA is often used more potentially dangerous than home usage.
One of the interesting consequences of oxidation as the ultimate mechanism of damage is that antioxidants are experimentally very effective in reducing or preventing MDMA neurotoxicity, even at near-lethal doses of MDMA. Pre- or co-administration of large doses of vitamin C, vitamin E and alpha-lipoic acid are all effective.[50] [51] [52] The supplements tryptophan and 5-HTP (5-hydroxytryptophan, the immediate precursor to serotonin) are also somewhat protective, [53] presumably by reducing the access of the source of the (as yet unidentified) ultimately toxic species to the serotonin transporter. Likewise, pre-administration of SSRIs is also quite effective at reducing MDMA neurotoxicity. [54]
While the theoretical end of things is very interesting, a more pressing question is whether or not MDMA is neurotoxic in humans at recreational doses. In one experiment, human volunteers were given sensitive brain scans that measured the density of serotonin transporters (a marker of serotonin axon presence/health), then given 1.5 mg/kg of MDMA hydrochloride under lab conditions ('room temp', no dancing, etc.), then re-scanned a month later. There was no loss of serotonin transporter (SERT) density, indicating that the subjects did not suffer neurotoxicity at that dose and in that environment. [55]
Retrospective studies of users 'in the wild' are more difficult to evaluate. One group of extremely heavy MDMA users that had quite low SERT density (a study championed as proof of MDMA neurotoxicity in humans by the US government) were still within the range of densities normally seen in healthy humans [56], leaving causality a very open question. Other brain scan studies have failed to find any reduction in SERT density among some groups of heavy users and only transient reductions in others. [57] Transient SERT density reductions appear to be a function of time since last dose, suggestive of a neuroadaptive response rather than axon loss.[58] The largest study to date found small reductions in SERT density in current users, but abstinant users had regional and total SERT densities identical to non-drug users.[75] Regrowth of axons after neurotoxic 'pruning' could explain the recovery of normal total SERT density, but not the recovery of normal regional SERT density; serotonin axon regrowth in non-human primates after a neurotoxic dose of MDMA results in hyperenervation of regions near the raphe nuclei but fails to restore enervation to more distal regions, creating a profound redistribution of serotonin axons in 'recovered' animals.[76][77]
Cerebral blood flow measurements of users have also been done, both retrospectively [59] and prospectively [60] (on human volunteers). In both cases, the MDMA exposed group did not show persistently reduced or abnormal regional or total cerebral blood flow.
Some mention must also be made of retrospective user cognitive function studies, which tend to receive more press than the more technical study methods. The most common finding is reduced verbal memory in MDMA users vs. controls. However, these studies are consistently riddled with confounds, most typically the presumption of no preexisting differences between the groups, nonrandom sampling, and failure to address the question of reversible neuroadaptation such as serotonin receptor downregulation after MDMA exposure, which can take weeks to fully reverse.[61] To date, there hasn't been a single study that I would regard as rigorous enough to give meaningful data on the long-term effects of MDMA use in humans...hopefully better experimental designs will appear in the future.
Also important is the heavy concomitant marijuana use seen among the recruited 'ecstasy' users. When controlled for marijuana use, differences in cognitive function scores between ecstasy users and non-users are greatly reduced [62] or eliminated entirely. [63]
In the end, two statements can be made about MDMA's neurotoxic potential with complete confidence. The first is that this drug clearly has the potential to cause extensive destruction of serotonin axons at some (high) dosage under the right circumstances. The second is that there is also very compelling evidence that MDMA has been used recreationally by many humans, even hundreds of times, without suffering structurally detectable (much less clinically significant) neurotoxicity. The government view that MDMA users are inherently damaging their brains is contradicted by the totality of the research, but there is at least theoretically the potential for harm at very high doses and/or under the wrong circumstances. User beware. (For a detailed discussion of the current research, visit the Neurotoxicity page.)